MedTrace Logo

Cardiac MRI for Post-TAVR Paravalvular Leak Assessment

NCT03195114 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2020-05-05

No results posted yet for this study

Summary

The objectives of this study are to: a) evaluate and correlate the severity of paravalvular leak (PVL) assessed by both cardiac MRI and transthoracic echocardiography (TTE) after transcatheter aortic valve replacement (TAVR) with Medtronic Evolut-R or Evolut PRO bioprostheses; b) assess the inter and intraobserver variability of both imaging methods; and c) correlate the severity of PVL with post-TAVR changes in LV remodeling and clinical outcomes.

Conditions

  • Paravalvular Leak

Interventions

DIAGNOSTIC_TEST

Multimodality Imaging and Biomarkers

Cardiac MRI, Cardiac MDCT, Echocardiography and Biomarkers Testing

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Eligibility

Min Age
60 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2019-02-15
Completion
2019-02-15

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03195114 on ClinicalTrials.gov